Consensus for 2025 revenue is $369.52M. Still sees adjusted net income positive each quarter and for full year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- GeneDx reports Q2 adjusted EPS 50c, consensus 11c
- GeneDx Holdings: Strong Market Position and Growth Potential in Rare Disease Testing
- GeneDx initiated with an Overweight at Piper Sandler
- GeneDx price target raised to $115 from $88 at Guggenheim
- GeneDx announces SeqFirst study data on rapid genomic testing in pediatrics